ASCEND by BenchSci harnesses proprietary text and image-based machine learning models, empowering scientists to dramatically improve the speed and success of research at any stage of pre-clinical drug development TORONTO, CANADA – BenchSci, a world leader in AI solutions for preclinical life sciences research and development (R&D), today announced a $95 million (US $70 million) […]
SOPHiA DDM™ deep-learning algorithm will help determine HRD status of tumors for Institute of Oncology Ljubljana researchers BOSTON and LAUSANNE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that the Institute of Oncology Ljubljana (IOL), a comprehensive public institution for detection, treatment and research of cancer, based […]
– Precision diagnostics crucial for targeted cancer treatment Qlucore, a company listed on Nasdaq First North, is in the process of obtaining CE certification for its cancer diagnostic software. The company has contracted the British Standards Institution (BSI) as the Notified Body to conduct the Conformity Assessment of Qlucore Diagnostics‘ acute lymphoblastic leukemia devices. BSI […]
MIAMI, FLORIDA & DALLAS, TEXAS – OmicsEdge has launched an industry leading drug discovery service that leverages Almaden’s g.nome™ platform to streamline the iteration process. The service makes it easy for labs to conduct a quick analysis of a patient or trial participant’s medical condition and genomics, gaining valuable insight in genomic criteria and how it affects elevated […]
SOPHiA GENETICS technology will help increase cancer research abilities BOSTON and LAUSANNE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Natural State Laboratories, a xfull-service, state-of-the-art molecular laboratory based in Little Rock, Arkansas, has chosen SOPHiA GENETICS technology to help them expand their cancer testing and […]
– Initial feature at no-cost to enable broad scalability of interpretation software to benefit sequencing labs of all sizes around the world – NEW YORK — Dante Genomics, a global leader in genomics and precision medicine, today announced a free, initial feature of its platform agnostic proprietary B2B software to automatically turn FASTQ files to VCF files […]
In just one year of using SOPHiA DDM™ HRD, Dasa reaches 2,000 samples analyzed BOSTON and LAUSANNE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and the leader in data-driven medicine, celebrates today with longstanding partner, Dasa, the largest integrated healthcare network in Brazil, as it reaches a milestone of 2,000 samples analyzed for HRD […]
Espoo, Finland. Euformatics, a Finnish bioinformatics company that develops world-leading NGS interpretation and quality control tools, has announced a distribution partnership with Zahrawi Group, a regional distributor in the Gulf area for, Surgical, Medical, Nuclear Medicine, Diagnostic, Analytical Lab, consumables and software. The agreement covers the markets of Bahrain, Oman and United Arab Emirates (UAE) […]
Updated Microservices and Front End Architectures Deliver Vastly Improved Performance and User Experience, while ML-ready Data Fuel Biomarker Discovery via ResponderID Boston – Genialis, a computational precision medicine company unraveling complex biology to find new ways to treat disease, today released Genialis(™) Expressions version 3.0 to accelerate translational and clinical biomarker discovery. Expressions is a platform […]
SOPHiA GENETICS expands footprint in India as Unipath Specialty Laboratory Limited is now live on SOPHiA DDM™ HRD Solution BOSTON & LAUSANNE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Unipath Specialty Laboratory Limited, one of the leading diagnostic brands […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
